NCT06282874 2026-04-09
Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases
Guangdong Association of Clinical Trials
Phase 4 Active not recruiting
Guangdong Association of Clinical Trials
Aristotle University Of Thessaloniki
City of Hope Medical Center
Weill Medical College of Cornell University
University of Michigan
Endeavor Health